生信3分+期刊,你可以考虑一下这个

后台有粉丝留言推荐一个3分加的期刊,为了满足粉丝的需求,小编立刻进行安排。为什么要推荐这个期刊呢?因为最近朋友的课题组中了2篇,还说不是很难。

期刊名字:Artificial Cells, Nanomedicine, and Biotechnology: An International Journal 

IF:2018年影响因子为4.46,2019的影响因子还在计算中,估计也快出来了

审稿周期:2-5月

遗憾的地方:需要2500美金的版面费

期刊被下面这些数据库收录:

Academic Search Complete; Biochemistry and Biophysics Citation Index; Biological Abstracts; Biomedical Reference Collection: Comprehensive; BIOSIS Full Coverage Shared; BIOSIS Previews; Biotechnology Abstracts; Biotechnology Citation Index; COMPENDEX; DOAJ; EMBASE; EMBIOLOGY; Journal Citation Reports/Science Edition; Materials Science Citation Index; PubMed/MedLine; Science Citation Index; SciSearch; SCOPUS; SIIC.

期刊覆盖的领域:

Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics:

artificial cells

blood substitutes and oxygen therapeutics

nanotechnology, nanobiotechnology, nanomedicine

tissue engineering

stem cells

bioencapsulation

microencapsulation and nanoencapsulation

microparticles and nanoparticles

liposomes

cell therapy and gene therapy

enzyme therapy

drug delivery systems

biodegradable and biocompatible polymers for scaffolds and carriers

biosensors

immobilized enzymes and their uses

other biotechnological and nanobiotechnological approaches

前面文章:

不知不觉,这篇文章竟然投了十个期刊

看完这篇非肿瘤的生信数据挖掘,你还会觉得难吗

看完这个,你还敢去买论文?

TCGA数据建模,GEO数据验证,结果文章直接被毙掉了

跟你们说,这样子的非肿瘤生信也很好发

(0)

相关推荐